Cargando…

LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription

Because of the lack of sensitivity to radiotherapy and chemotherapy, therapeutic options for renal clear cell carcinoma (KIRC) are scarce. Long noncoding RNAs (lncRNAs) play crucial roles in the progression of cancer. However, their functional roles and upstream mechanisms in KIRC remain largely unk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Xina, Lin, Jiatian, Fan, Xiaoqin, Zhong, Yuantang, Chen, Yequn, Liu, Kaiqing, Ren, Yonggang, Chen, Xiangling, Lai, Daihuan, Li, Xuyi, Li, Zesong, Tang, Aifa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895987/ https://www.ncbi.nlm.nih.gov/pubmed/33608495 http://dx.doi.org/10.1038/s41419-021-03489-y

Ejemplares similares

NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating HMGA2 Transcription through KDM2A-mediated H3K36me2 Demethylation
por: Lin, Jiatian, et al.
Publicado: (2022)

FGFR(3S249C) mutation promotes chemoresistance by activating Akt signaling in bladder cancer cells
por: Xie, Xina, et al.
Publicado: (2019)

Expression and clinical significance of NUF2 in kidney renal clear cell carcinoma
por: Shan, Li, et al.
Publicado: (2021)

Identification of adhesion-associated extracellular matrix component thrombospondin 3 as a prognostic signature for clear cell renal cell carcinoma
por: Chen, Xiangling, et al.
Publicado: (2022)

Corrigendum: Correction Of The Figure. Identification of adhesion-associated extracellular matrix component thrombospondin 3 as a prognostic signature for clear cell renal cell carcinoma
por: Chen, Xiangling, et al.
Publicado: (2023)

NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma
por: Zheng, Baishu, et al.
Publicado: (2023)

Identification of a Novel Epigenetic Signature CHFR as a Potential Prognostic Gene Involved in Metastatic Clear Cell Renal Cell Carcinoma
por: Chen, Xiangling, et al.
Publicado: (2021)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 Are Associated with Type 2 Diabetes in a Chinese Population
por: Hu, Cheng, et al.
Publicado: (2009)

CircRNA-mediated regulation of brown adipose tissue adipogenesis
por: Liu, Kaiqing, et al.
Publicado: (2022)

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
por: Liu, Huidi, et al.
Publicado: (2020)

Association Between CDKAL1, HHEX, CDKN2A/2B and IGF2BP2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes in Uttarakhand, India
por: Verma, Amit K, et al.
Publicado: (2021)

Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers
por: Jiang, Xiaodan, et al.
Publicado: (2021)

Four pairs of gene–gene interactions associated with increased risk for type 2 diabetes (CDKN2BAS–KCNJ11), obesity (SLC2A9–IGF2BP2, FTO–APOA5), and hypertension (MC4R–IGF2BP2) in Chinese women
por: Wang, M.H., et al.
Publicado: (2014)

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis
por: Jiang, Feng, et al.
Publicado: (2022)

NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1
por: Shan, Jijun, et al.
Publicado: (2023)

CD44(+) fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3‐CD44‐IGF2 signalling
por: Liu, Yonglei, et al.
Publicado: (2017)

Nuf2 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Hepatocellular Carcinoma
por: Xie, Xingwei, et al.
Publicado: (2021)

ANP32E contributes to gastric cancer progression via NUF2 upregulation
por: Zhu, Xiaowen, et al.
Publicado: (2022)

siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo
por: Hu, Peng, et al.
Publicado: (2015)

Nuf2, a spindle pole body-associated protein required for nuclear division in yeast
Publicado: (1994)

Interaction of PTPIP51 with Tubulin, CGI-99 and Nuf2 During Cell Cycle Progression
por: Brobeil, Alexander, et al.
Publicado: (2012)

Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer
por: Xu, Wenjie, et al.
Publicado: (2019)

Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer
por: Zhai, Xiuming, et al.
Publicado: (2020)

NUF2 Is a Potential Immunological and Prognostic Marker for Non-Small-Cell Lung Cancer
por: Li, Xia, et al.
Publicado: (2022)

NUF2 Promotes Breast Cancer Development as a New Tumor Stem Cell Indicator
por: Deng, Yang, et al.
Publicado: (2023)

IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer
por: Chou, Chia-Hsuan, et al.
Publicado: (2020)

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target
por: Shantha Kumara, HMC, et al.
Publicado: (2015)

Small interfering RNA-mediated knockdown of KRT80 suppresses colorectal cancer proliferation
por: Lin, Jiatian, et al.
Publicado: (2020)

Common Variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE Genes Are Associated With Type 2 Diabetes and Impaired Fasting Glucose in a Chinese Han Population
por: Wu, Ying, et al.
Publicado: (2008)

Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk
por: Tang, Weifeng, et al.
Publicado: (2018)

circPLIN2 promotes clear cell renal cell carcinoma progression by binding IGF2BP proteins and miR-199a-3p
por: Zhao, Bin, et al.
Publicado: (2022)

Role of IGF2BP3 in trophoblast cell invasion and migration
por: Li, W, et al.
Publicado: (2014)

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
por: Sun, Chao, et al.
Publicado: (2021)

Evaluation of the Association of IGF2BP2 Variants With Type 2 Diabetes in French Caucasians
por: Duesing, Konsta, et al.
Publicado: (2008)

IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma
por: Wang, Xiangpu, et al.
Publicado: (2022)

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
por: Hu, Xiaoge, et al.
Publicado: (2019)

Implication of Genetic Variants Near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in Type 2 Diabetes and Obesity in 6,719 Asians
por: Ng, Maggie C.Y., et al.
Publicado: (2008)

Impact of Common Variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the Risk of Type 2 Diabetes in 5,164 Indians
por: Chauhan, Ganesh, et al.
Publicado: (2010)

Association Analysis of Variation in/Near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B With Type 2 Diabetes and Related Quantitative Traits in Pima Indians
por: Rong, Rong, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1h02c8h2kani0qkg0tje8ltpr9